StudyLancet review: cannabinoids in chronic non-cancer pain — updated evidence synthesisRegulatoryGermany: BfArM publishes updated guidance on medicinal cannabis prescribingStudyNEJM: CBD adjunctive therapy in treatment-resistant epilepsy — long-term follow-upRegulatoryTGA Australia releases revised Special Access Scheme statisticsBusinessTilray and Aphria file expanded EU-GMP medical cannabis distribution agreementsRegulatoryUK MHRA consults on unlicensed cannabis-based medicinal products frameworkStudyJAMA: cannabinoids in chemotherapy-induced nausea — systematic review updateBusinessCanopy Growth restructures European operations amid German market expansionRegulatorySwissmedic authorises additional medicinal cannabis product classificationsStudyIACM publishes 2026 international consensus on cannabinoid dosing in palliative careStudyLancet review: cannabinoids in chronic non-cancer pain — updated evidence synthesisRegulatoryGermany: BfArM publishes updated guidance on medicinal cannabis prescribingStudyNEJM: CBD adjunctive therapy in treatment-resistant epilepsy — long-term follow-upRegulatoryTGA Australia releases revised Special Access Scheme statisticsBusinessTilray and Aphria file expanded EU-GMP medical cannabis distribution agreementsRegulatoryUK MHRA consults on unlicensed cannabis-based medicinal products frameworkStudyJAMA: cannabinoids in chemotherapy-induced nausea — systematic review updateBusinessCanopy Growth restructures European operations amid German market expansionRegulatorySwissmedic authorises additional medicinal cannabis product classificationsStudyIACM publishes 2026 international consensus on cannabinoid dosing in palliative care
Institute for Cannabinoid Therapy emblem
Institute for Cannabinoid Therapy
Est. International Education
Legal

Privacy Policy

This page is maintained by the Institute for Cannabinoid Therapy to describe how personal information is handled when you use this website and its educational services. It will be updated as the Institute's practices evolve.